Jennifer Stevens, Chief Regulatory Officer at TriSalus Life Sciences, Inc. (TLSI), sold 3,530 shares at $4.13 ($15K) on 2026-03-11, disclosed to the SEC on 2026-03-20.
Open-market sale of $15k TLSI by Chief Regulatory Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.13 | 1,204 | $5K | 34.3% |
| 2 | $4.09 | 1,552 | $6K | 43.7% |
| 3 | $4.12 | 774 | $3K | 22.0% |
| Total | $4.11 avg | 3,530 | $15K | 100% |
| Filing → |